Polynucleotides in Dubai

Polynucleotides are injectable products containing purified chains of nucleotides, the building blocks of DNA. In aesthetic medicine, selected formulations are used with the aim of improving skin quality, including concerns involving texture, fine lines and elasticity. They are generally discussed as skin-rejuvenation treatments rather than products intended to reshape facial contours.

Dr. Camellia Kamyab considers polynucleotides through an individual assessment of skin condition, facial anatomy and previous treatments. The priority is to establish whether the proposed product addresses a genuine concern and is suitable for the patient.

Nucleotide Chains and Their Proposed Role

Polynucleotides are being studied for their effects on processes involved in tissue repair and skin maintenance. Some formulations contain highly purified DNA-derived material, commonly sourced from fish.

Early clinical studies have reported improvements in certain measures of skin texture, fine wrinkles and elasticity. However, research remains relatively limited, and larger studies are needed to establish which formulations and treatment schedules provide reliable benefits.

PN and PDRN Are Not Identical Labels

Polynucleotides (PN) and polydeoxyribonucleotides (PDRN) are related DNA-derived materials, but products can differ in fragment size, concentration, preparation and intended use. They should not be assumed to have identical effects.

The specific product matters more than the broad label. Claims about one formulation cannot automatically be applied to every injectable advertised as a polynucleotide treatment.

Skin Concerns That May Enter the Discussion

A consultation looks at the type of change rather than simply deciding to inject a particular ingredient. Areas of concern that may warrant discussion include:

Fine lines and superficial creasing
Uneven or rough-looking skin texture
Early loss of elasticity or suppleness
Delicate skin around the eyes, where suitable
Changes in skin quality across the neck or décolletage
Interest in gradual, subtle skin refinement

Pronounced hollowing, significant laxity or pigmentation may require different care. Polynucleotides are not a universal solution for every sign of ageing.

The Difference From Volume-Building Fillers

A structural dermal filler is selected to augment or support particular contours. Polynucleotide products are generally intended for a different objective: supporting aspects of skin quality without substantial reshaping.

For Dr. Camellia, this distinction is important. If a concern is primarily caused by tissue descent or lost volume, skin-focused injections alone may offer limited improvement. Treatment begins with identifying the cause, not choosing the newest formulation.

Purification, Source and Suitability

Some polynucleotide products are derived from purified salmon or trout DNA, while exact sourcing and processing vary between manufacturers. Product quality, sterility, composition and regulatory status deserve careful review.

Patients should disclose relevant allergies, including fish-related allergies where applicable. The safety profile of one product cannot be assumed to apply to all products, and use should follow the manufacturer’s instructions and locally authorised indications.

Book a Consultation

Clinical Details Before the First Injection

An assessment helps identify factors that may influence treatment safety and individual response. Dr. Camellia may review:

Previous skin boosters, fillers and regenerative procedures
Skin sensitivity and tendency towards pigmentation
Infection or inflammation in the proposed area

Allergies, medications and relevant health conditions
Pregnancy or breastfeeding, when elective treatment is generally deferred
Expectations about downtime and visible improvement

These details help determine whether an injectable is appropriate or if another treatment route is preferable.

Small Injection Sites, Careful Aftercare

If treatment is suitable, the selected formulation is administered through a series of small injections, using a technique appropriate to the product and anatomical area. Temporary bumps, swelling, tenderness or bruising can follow.

Patients receive individual aftercare instructions. Increasing pain, spreading redness, unusual skin changes or other concerning symptoms should be medically assessed, as injection procedures carry risks including infection and adverse reactions.

Skin Response Cannot Be Rushed

Changes, if they occur, are generally assessed over weeks rather than immediately. Some protocols use more than one session, but timing should reflect the specific product and clinical indication rather than a standard promise of results.

Polynucleotides cannot reliably erase deep wrinkles, eliminate eye bags or prevent future skin ageing. The current evidence is encouraging in selected settings but does not justify guaranteed outcomes.

A Measured Choice for Regenerative Skin Care

Polynucleotide treatment may be considered within a wider skin-quality strategy, alongside appropriate skincare and other treatments when indicated. More procedures do not necessarily lead to better results.

Patients considering polynucleotides in Dubai can arrange a consultation with Dr. Camellia Kamyab to discuss their skin concerns, treatment history and realistic expectations. The aim is to select an appropriate option that respects the skin and preserves natural facial expression.